News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Tennessee
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
January 21, 2025
·
10 min read
Press Releases
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
January 21, 2025
·
4 min read
Press Releases
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
January 17, 2025
·
4 min read
Press Releases
Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases
January 16, 2025
·
3 min read
Press Releases
Veteran Clinical Research Executive Steve Clemons Joins ObjectiveHealth as CEO
January 16, 2025
·
3 min read
Press Releases
Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs
January 15, 2025
·
5 min read
Press Releases
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics
January 15, 2025
·
2 min read
Press Releases
Virtuoso Surgical Robot Helps Enable Innovative ARPA-H Project on Artificial Intelligence
January 14, 2025
·
4 min read
Press Releases
Currax Announces Outstanding 2024 Financial and Operational Performance
January 10, 2025
·
9 min read
Press Releases
NashBio Announces New Suite of Strategic Data Solutions to Accelerate Life Science Research and Development
January 10, 2025
·
3 min read
Press Releases
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
January 7, 2025
·
5 min read
Press Releases
Healthcare Integrated Technologies, Inc. Promotes Dustin Hillis to President
December 30, 2024
·
2 min read
Press Releases
Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative
December 30, 2024
·
3 min read
Press Releases
Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
December 19, 2024
·
3 min read
Press Releases
Aegis Sciences Corporation Collaborates with The McNabb Center to Evaluate the Impact of Xylazine Exposure on Opioid Withdrawal
December 17, 2024
·
3 min read
Press Releases
Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer
December 16, 2024
·
3 min read
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
·
5 min read
Press Releases
Aegis Sciences Corporation Announces Updates for NPS Testing
December 10, 2024
·
2 min read
Press Releases
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
December 9, 2024
·
9 min read
Press Releases
Sarah Cannon Research Institute to Showcase Latest Research Insights at the 2024 ASH Annual Meeting & Exposition
December 6, 2024
·
4 min read
